Skip to content

Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat

Prospective Registry of Outcome and Correlates of Chemosensory Dysfunction at the Smell & Taste Clinic of UZ Leuven

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06456008
Acronym
ProspeRo'Scent
Enrollment
500
Registered
2024-06-13
Start date
2022-12-06
Completion date
2035-12-31
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Olfactory Disorder, Smell Disorder, Smell Dysfunction, Taste Disorders

Brief summary

Smell/taste disorders are common conditions with a significant impact on quality of life. In September 2021, a specific consultation for patients with smell and taste disorders was initiated at the ENT-HNS (ear, nose, and throat, head and neck surgery) department of UZ Leuven, partly in light of post-COVID-19 related smell disorders. With this observational ambidirectional study, the investigators aim to better map smell/taste disorders in the Belgian/Flemish population. Using standard-of-care diagnostic tests and structured questionnaires, the investigators strive to gain more insight into the severity, impact, and progression/prognosis of smell/taste disorders.

Interventions

OTHERStandard of care

Standard of care

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL

Inclusion criteria

* The psychophysical testing as well as the questionnaires require a cooperative participant who can understand and follow instructions and communicate their choices. * Informed consent is necessary upon participation for prospective registry. There are no

Exclusion criteria

related to sex, gender, or ethnicity. There are no

Design outcomes

Primary

MeasureTime frame
Chemosensory functionObservational up to 5 years follow-up

Countries

Belgium

Contacts

Primary ContactMarnick Clijsters
marnick.clijsters@gmail.com003216348044

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026